
About Petri Bio
Petri Bio is a Healthcare company based in Los Angeles (United States) founded in 2019 by Joseph Schinaman. Microbe-based drugs are manufactured by Petri Bio in biotechnology. The company has 2 employees. Its focus areas include Traditional Pharmaceuticals.
Company details
Petri Bio was founded in 2019 in Los Angeles, United States, with Joseph Schinaman serving as co-founder. Operations are centered on the production of drugs derived from microbes within the biotechnology sector. Manufacturing processes emphasize microbial technologies for pharmaceutical development. The company is headquartered in Los Angeles, and its online presence is maintained through the domain petribio.com. Focus remains on factual advancements in microbe-sourced therapeutics.
- Headquarters Los Angeles, United States
- Employees 2
- Founders Joseph Schinaman
- SectorsHealthcare
- Website petribio.com
- Social LinkedIn
- Net Profit-$49.26 K (USD)as on Dec 30, 2020
- Latest Funding Round$1M (USD), Grant
May 2022
- Investors
- Employee Count2
Funding Insights of Petri Bio
- Total Rounds 2
- Last Round Grant β $1M
- First Round $361,931
(Sep 2021)
- Investors Count 1
All 2 funding rounds of Petri Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Petri Bio
Petri Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Petri Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Petri Bio
2 people are tracked at Petri Bio (2 in leadership); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Joseph Schinaman | Co-Founder | Leadership |
Shu Li | Co-Founder and CEO | Leadership |
Complete people profiles for Petri Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Petri Bio
3 dated milestones of Petri Bio across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Petri Bio is founded.
- Funding First funding round of $362K.
- Funding Latest funding round, Grant, of $1.0M.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Petri Bio (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Petri Bio
Petri Bio was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Petri Bio is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Petri Bio has 2 employees.
Petri Bio was founded in 2019 in Los Angeles, United States, with Joseph Schinaman serving as co-founder. Operations are centered on the production of drugs derived from microbes within the biotechnology sector. Manufacturing processes emphasize microbial technologies for pharmaceutical development. The company is headquartered in Los Angeles, and its online presence is maintained through the domain petribio.com. Focus remains on factual advancements in microbe-sourced therapeutics.
Petri Bio has 1 investor. Key investors include HHS.